DuPont Forecasts Growth of its Photovoltaic Sales

Owing to increased demand for novel installations in North America, Europe and certain regions of Asia, DuPont expects its sales of photovoltaic products to grow more than 50% in 2010. The company hopes its photovoltaic sales to cross $1 billion by 2011 and $2 billion by 2014.

DuPont’s president for Electronics & Communications David B. Miller stated that the materials offered by the company offer superior reliability and performance to photovoltaic modules. The company also offers customized solutions to customers.

In 2009, the company’s photovoltaics sales crossed $550 million, which is a 25% increase from 2008 and outperformed the industry performance that showed a decline in growth of around 10%. This growth can be attributed to the company’s new innovations, which help improve lifetime and module efficiency and also facilitate novel photovoltaic applications and technologies.

DuPont Photovoltaic Solutions offers over 10 products crucial to the production of photovoltaics. DuPont technology and materials are developed in such a way as to enhance the lifetime and efficiency of thin-film photovoltaic and crystalline silicon solar modules, while decreasing the cost of systems.


Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Azthena logo powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Azthena logo with the word Azthena

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.